Day: May 14, 2025

Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor. At the Annual Meeting, the Company will highlight its growing portfolio of pediatric-specific solutions, including OrthoPediatrics Specialty Bracing (“OPSB”) and Enabling Technologies, at its three exhibit booths. OrthoPediatrics has established a long-term commitment to POSNA providing ongoing support of specialty symposiums and awarding educational grants and scholarships to attendees. The Company is the only Emerald Sponsor of the meeting. OrthoPediatrics’...

First-Quarter 2025 revenue of $107.5 million grew 20% primarily due to 21% growth in subscription revenue ARR grew 23% to $408.0 million First-Quarter 2025 adjusted EBITDA of $23.7 million, 22.0% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 14, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three months ending March 31, 2025. “Cellebrite delivered strong 23% ARR growth while pairing solid revenue expansion with prudent spending to drive 34% year-over-year growth in adjusted EBITDA and a 22% margin,” stated Thomas E. Hogan, Cellebrite’s interim CEO. “The strength of our total performance was a byproduct of our global diversification and the range of our solutions across...

– Revenue of $67 million, up 33% Y/Y –– Gross mining margin of 43%, down from 63% from Q1 2024 –– Total energy pipeline of ~1.4 GW, ~80% based in the U.S. –– Private debt facility announced in April 2025 with division of Macquarie Group for up to $300 million to fund initial HPC project development at Panther Creek, validating the attractiveness of Bitfarms’ potential HPC data center development pipeline –  This news release constitutes a “designated news release” for the purposes of the Company’s second amended and restated prospectus supplement dated December 17, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario, May 14, 2025 (GLOBE NEWSWIRE) — Bitfarms Ltd. (Nasdaq/TSX: BITF), a global vertically integrated Bitcoin data center company, reported...

MONTREAL, May 14, 2025 (GLOBE NEWSWIRE) — Boralex Inc. (“Boralex” or the “Corporation”) (TSX: BLX) is pleased to report its results for the first quarter of 2025. Highlights Financial resultsLower EBITDA(A)1, operating income and net earnings in Q1-2025Production down 4% (1% on a Combined1 basis)2 from Q1-2024 and 10% (11%) below anticipated production1. Good weather conditions in Canada partially offset less favourable conditions in France. EBITDA(A) of $176 million ($199 million) in Q1-2025, down $19 million ($19 million) from Q1-2024, mainly attributable to lower production and short-term power purchase agreements prices that were more favourable in Q1-2024, in France. Operating income of $65 million ($99 million) in Q1-2025, down $41 million ($35 million) from Q1-2024. Net earnings of $41 million in Q1-2025, down $32 million...

Collaboration combines Novo Nordisk’s scientific leadership in obesity and cardiometabolic diseases with Septerna’s expertise in G protein-coupled receptor (GPCR) drug discovery  Goal is to develop multiple oral small molecule therapies for key GPCR targets, including GLP-1, GIP and glucagon receptors Septerna is eligible to receive approximately 2.2 billion US dollars, including more than 200 million dollars in upfront and near-term paymentsSouth San Francisco, California, US and Bagsværd, Denmark, 14 May 2025 – Septerna, Inc. (Nasdaq: SEPN) and Novo Nordisk today announced an exclusive global collaboration and license agreement to discover, develop and commercialise oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases. The companies will initially commence four development programmes for potential...

PETAH-TIKVA, Israel, May 14, 2025 (GLOBE NEWSWIRE) — Global-e Online Ltd. (Nasdaq: GLBE) the leader of global Direct-To-Consumer eCommerce enablement, and Shopify, a leading commerce technology company, today announced a new 3-year strategic partnership agreement. The new agreement renews the companies’ long-standing strategic partnership for both their 1P (i.e. Shopify Managed Markets) and 3P solutions to empower international direct to consumer e-commerce on the Shopify platform. “As the leader in this market, Global-e has been a great partner of ours for over four years now, helping Shopify merchants realize their true global potential,” said Kaz Nejatian, COO of Shopify. “Our renewed agreement enables us to take our offering to the next level and enhance opportunities and optionality for merchants of all sizes,...